Pacific Biosciences of California News

Pacific Biosciences of California | ARS: Annual Report to Security Holders

Apr 29 08:23 ET

Pacific Biosciences of California | DEFA14A: Others

Apr 29 08:23 ET

Pacific Biosciences of California | DEF 14A: Definitive information statements

Apr 29 08:18 ET

Pacific Biosciences of California | 8-K: PacBio Announces Preliminary First Quarter 2024 Revenue and Updates 2024 Revenue Guidance Announces Plan to Reduce Annualized Operating Expense Run Rate by $50 - $75 Million Q1 2024 Earnings Conference Call Schedul

Apr 16 08:09 ET

Pacific Biosciences of California | PRE 14A: Preliminary proxy statements relating to merger or acquisition

Apr 15 08:18 ET

Pacific Biosciences of California | POSASR: Post-effective amendment to an automatic shelf registration statement on Form S-3ASR or Form F-3ASR

Apr 11 17:06 ET

Pacific Biosciences of California | POSASR: Post-effective amendment to an automatic shelf registration statement on Form S-3ASR or Form F-3ASR

Apr 11 17:06 ET

Pacific Biosciences of California | POSASR: Post-effective amendment to an automatic shelf registration statement on Form S-3ASR or Form F-3ASR

Apr 11 17:06 ET

Pacific Biosciences of California | 4: Statement of changes in beneficial ownership of securities-Director ORDONEZ KATHY

Mar 19 16:27 ET

Pacific Biosciences of California | 4: Statement of changes in beneficial ownership of securities-Director Meline David W

Mar 6 17:40 ET

Pacific Biosciences of California | 4: Statement of changes in beneficial ownership of securities-Officer Farmer Michele

Mar 6 17:36 ET

Pacific Biosciences of California | 4: Statement of changes in beneficial ownership of securities-Officer Van Oene Mark

Mar 6 17:31 ET

Pacific Biosciences of California | 4: Statement of changes in beneficial ownership of securities-Officer Kim Susan G.

Mar 6 17:26 ET

Pacific Biosciences of California | 4: Statement of changes in beneficial ownership of securities-Officer HENRY CHRISTIAN O

Mar 6 17:16 ET

Pacific Biosciences of California | 4: Statement of changes in beneficial ownership of securities-Director MOHR MARSHALL

Mar 5 16:33 ET

Pacific Biosciences of California | 144: Notice of proposed sale of securities pursuant to Rule 144

Mar 4 18:36 ET

Pacific Biosciences of California | 144: Notice of proposed sale of securities pursuant to Rule 144

Mar 4 18:27 ET

Pacific Biosciences of California | 144: Notice of proposed sale of securities pursuant to Rule 144

Mar 4 17:41 ET

Pacific Biosciences of California | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans

Feb 29 13:58 ET

Pacific Biosciences of California | 10-K: Annual report

Feb 28 22:40 ET